세계의 무좀 시장 : 질환 유형별, 치료 유형별, 투여 경로별, 유통 채널별, 지역별.
Global Athlete´s Foot Market, By Disease Type, By Treatment Type, By Route of Administration, By Distribution Channel, By Geography .
상품코드
:
1454241
리서치사
:
Coherent Market Insights
발행일
:
2024년 02월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계 발백선 시장은 2023년에는 14억 1,000만 달러로 평가되었고, 2031년에는 20억 6,000만 달러에 이를 것으로 예측되며, 2024년부터 2031년까지 복합 연간 성장률(CAGR) 4.8%로 성장할 것으로 예측됩니다.
| 보고 범위 |
보고서 세부정보 |
| 기준년 |
2023 |
2023/2024년 시장 규모 |
14억 1,000만 달러 |
| 실적 데이터 |
2019년-2023년 |
예측 기간 |
2024-2031 |
| 예측 기간 2023/2024-2030/2031 복합 연간 성장률(CAGR): |
4.80% |
2030년/2031년 가치 예측 |
20억 6,000만 달러 |
그림 1. 무좀 시장 점유율(%), 지역별(2024년)
무좀은 발 피부, 특히 발가락 사이를 침범하는 일반적인 곰팡이 감염이지만 발톱과 손으로 퍼질 수 있습니다. 이 곰팡이는 스포츠를 하는 사람에게 흔히 볼 수 있는 땀을 흘린 신발 속 등 따뜻하고 습한 환경에서 번식하기 때문에 스포츠 선수에게 흔히 볼 수 있기 때문에 "무좀"이라고 명명되었습니다. 이 증상은 발가락 사이와 발바닥의 가려움, 따끔 거림, 작열감이 특징입니다. 감염된 부위의 피부는 빨갛게 되고, 찢어지거나, 금이 가거나, 물집이 되기도 합니다. 불쾌한 증상이지만 일반적으로 가벼우며 시판되는 항진균제로 치료할 수 있습니다. 끈질기거나 심한 경우에는 처방전에 의한 강력한 치료가 필요할 수 있습니다. 무좀은 피부 사상균(피부의 오래된 표피에서 자라는 진균의 일종)에 의해 유발됩니다. 이 곰팡이는 오염 된 표면과 직접 접촉하거나 수건, 신발, 의복 등과의 간접 접촉으로 쉽게 퍼집니다. 공동 샤워, 수영장, 탈의실은 감염의 핫스팟이며, 스포츠 선수와 체육관을 다니는 사람들은 특히 감염되기 쉽습니다. 무좀의 예방에는 발 위생 관리가 중요한 역할을합니다. 이것은 발을 깨끗하고 건조한 상태로 유지하고, 통기성이 좋은 신발을 신는 것, 양말을 정기적으로 바꾸는 것, 곰팡이가있을 수있는 공공 장소에서 맨발로 걷지 않는 것 등이 포함됩니다. 또한 무좀의 사람은 신체의 다른 부분이나 다른 사람에게 감염을 퍼지지 않도록주의해야합니다. 무좀의 조기 발견과 조기 치료는 감염의 관리가 어려워지고 더 심각한 2 차 박테리아 감염으로 이어지는 것을 방지하는 데 중요합니다. 원인, 예방 및 치료 옵션을 이해하면이 증상에 효과적으로 대처하고 발 건강을 유지할 수 있습니다.
시장 역학:
세계 무좀 시장은 주로 노인 인구 증가, 비만률 증가, 물놀이 참여 증가에 의한 감염증의 유병률의 상승이 견인하고 있습니다. 치료되지 않은 발의 곰팡이 감염의 영향에 대한 건강 의식 증가도 자기 진단과 상용 약물을 뒷받침합니다. 그러나 시판되는(OTC) 외용 크림이나 파우더를 사용한 가정 요법과 같은 대체 치료 옵션은 처방약의 수익 창출 가능성을 방해할 수 있습니다.
본 조사의 주요 특징
- 본 보고서에서는 세계 무좀 시장을 상세하게 분석하여 2023년을 기준년으로 한 예측기간(2024-2031년) 시장 규모 및 복합 연간 성장률(CAGR)%을 제공합니다.
- 또한 다양한 부문에 걸친 잠재적인 수익 기회를 밝히고, 이 시장에 대한 매력적인 투자 제안의 행렬을 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시와 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 주요 고찰도 제공합니다.
- 엔터프라이즈 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등과 같은 매개변수를 바탕으로 세계 무좀 시장에서 주요 기업을 프로파일링합니다.
- 이 보고서의 인사이트을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 타이핑, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
- 세계 무좀 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해 관계자를 지원합니다.
- 이해관계자는 세계 무좀 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.
목차
제1장 조사의 목적과 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 건강과 위생에 대한 의식 증가
- 퍼스널케어와 스포츠 헬스 케어에의 지출 증가
- 치료 옵션에서의 기술 진보
- 주요 하이라이트
- 규제 시나리오
- 최근 동향
- 제품 출시/승인
- PEST 분석
- Porter's Five Forces 분석
- 합병, 인수 및 협업
제4장 세계 무좀 시장-코로나바이러스(COVID-19) 팬데믹의 영향
- 신형 코로나 바이러스 감염증(COVID-19)의 역학
- 공급측과 수요측 분석
- 경제적 영향
제5장 세계 무좀 시장 : 약제 클래스별(2019년-2031년)
제6장 세계 무좀 시장 : 질환 적응별(2019년-2031년)
제7장 세계 무좀 시장 : 투여 경로별(2019년-2031년)
제8장 세계 무좀 시장 : 유통 채널별(2019년-2031년)
제9장 세계 무좀 시장 : 지역별(2019년-2031년)
- 북미
- 미국
- 캐나다
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 북아프리카
- 중앙 아프리카
제10장 경쟁 구도
- 기업 프로파일
- Perrigo Company Plc.
- Novartis AG
- Valeant Pharmaceuticals International
- GlaxoSmithKline plc
- Bayer AG
- Teva Pharmaceuticals Industries Ltd.
- Mylan NV
- Glenmark Pharmaceutical Ltd
- Taro Pharmaceutical Industries Ltd.
- Camber Pharmaceuticals Inc
- Aurobindo Pharma Ltd
제11장 섹션
BJH
영문 목차
The global athlete's foot market was valued at US$ 1.41 Bn in 2023 and is expected to reach US$ 2.06 Bn by 2031, growing at a compound annual growth rate (CAGR) of 4.8% from 2024 to 2031.
| Report Coverage |
Report Details |
| Base Year: |
2023 |
Market Size in 2023/2024: |
US$ 1.41 Bn |
| Historical Data for: |
2019 to 2023 |
Forecast Period: |
2024 - 2031 |
| Forecast Period 2023/2024 to 2030/2031 CAGR: |
4.80% |
2030/2031 Value Projection: |
US$ 2.06 Bn |
Figure 1. Global Athlete's Foot Market Share (%), By Region, 2024
Athlete's foot, also known as tinea pedis, is a common fungal infection that affects the skin on the feet, particularly the spaces between the toes, but can also spread to the toenails and hands. It is named "athlete's foot" because it is frequently seen in athletes, as the fungus thrives in warm, moist environments, such as the inside of sweaty shoes, which are common among sports participants. This condition is characterized by itching, stinging, and burning sensations between the toes or on the soles of the feet. The affected skin may also become red, flaky, cracked, or blistered. Although the condition can be uncomfortable, it is generally mild and can be treated with over-the-counter antifungal medications. In persistent or severe cases, prescription-strength treatments may be necessary. Athlete's foot is caused by dermatophytes, a type of fungus that grows on the dead outer layer of skin. The fungus spreads easily through direct contact with contaminated surfaces or through indirect contact with towels, shoes, or clothing. Communal showers, swimming pools, and locker rooms are hotspots for transmission, making athletes and gym-goers particularly susceptible. Good foot hygiene plays a crucial role in preventing athlete's foot. This includes keeping the feet clean and dry, wearing breathable footwear, changing socks regularly, and avoiding walking barefoot in public places where the fungus may be present. Individuals with athlete's foot should also be careful not to spread the infection to other parts of their body or to other people. Early detection and treatment of athlete's foot are important to prevent the infection from becoming more difficult to manage or leading to more serious secondary bacterial infections. Understanding the causes, prevention, and treatment options enables individuals to effectively deal with this condition and maintain good foot health.
Market Dynamics:
The global athlete's foot market is primarily driven by the rising prevalence of the infection due to a growing geriatric population, increasing obesity rates, and greater participation in aquatic activities. Growing health awareness regarding implications of untreated fungal infections of feet is also supporting self-diagnosis and over-the-counter medication. However, alternative treatment options such as home remedies using over-the-counter (OTC) topical creams and powders may hinder revenue generation potential for prescription drugs.
Key features of the study:
- This report provides in-depth analysis of the global athlete's foot market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global athlete's foot market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Perrigo Company Plc., Novartis AG, Valeant Pharmaceuticals International, GlaxoSmithKline plc, Bayer AG, Teva Pharmaceuticals Industries Ltd., Mylan NV, Glenmark Pharmaceutical Ltd, Taro Pharmaceutical Industries Ltd., Camber Pharmaceuticals Inc, Aurobindo Pharma Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global athlete's foot market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global athlete's foot market
Detailed Segmentation:
- Global Athlete's Foot Market, By Drug Class
- Global Athlete's Foot Market, By Disease Indication
- Interdigital
- Plantar
- Vesicular
- Global Athlete's Foot Market, By Route of Administration
- Global Athlete's Foot Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Athlete's Foot Market, By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Top Companies in Global Athlete's Foot Market:
- Perrigo Company Plc.
- Novartis AG
- Valeant Pharmaceuticals International
- GlaxoSmithKline plc
- Bayer AG
- Teva Pharmaceuticals Industries Ltd.
- Mylan NV
- Glenmark Pharmaceutical Ltd
- Taro Pharmaceutical Industries Ltd.
- Camber Pharmaceuticals Inc
- Aurobindo Pharma Ltd
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Athlete's Foot, By Drug Class
- Market Athlete's Foot, By Disease Indication
- Market Athlete's Foot, By Route of Administration
- Market Athlete's Foot, By Distribution Channel
- Market Athlete's Foot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Growing health and hygiene awareness
- Increasing spending on personal care and sports healthcare
- Technological advancements in treatment options
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Mergers, Acquisitions, and Collaborations
4. Global Athlete's Foot Market- Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Athlete's Foot Market, By Drug Class, 2019-2031, (US$ Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Antifungals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
- Combination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
6. Global Athlete's Foot Market, By Disease Indication, 2019-2031, (US$ Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020-2031
- Segment Trends
- Interdigital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
- Plantar
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
- Vesicular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
7. Global Athlete's Foot Market, By Route of Administration, 2019-2031, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Segment Trends
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
8. Global Athlete's Foot Market, By Distribution Channel, 2019-2031, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
9. Global Athlete's Foot Market, By Region, 2019-2031, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Country 2019 -2031
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Company Profile
- Drug Class Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Valeant Pharmaceuticals International
- GlaxoSmithKline plc
- Bayer AG
- Teva Pharmaceuticals Industries Ltd.
- Mylan NV
- Glenmark Pharmaceutical Ltd
- Taro Pharmaceutical Industries Ltd.
- Camber Pharmaceuticals Inc
- Aurobindo Pharma Ltd
Analyst Views
11. Section
- References
- Research Methodology
- About us
관련자료
